Intriguingly in one sample, both in primary tumor and cell culture specimens, MDM2 amplicons were preferentially amplified if compared to TP53 ones (ratio “mean amplicon coverage MDM2/ mean amplicon coverage TP53” = 16.5 and 10.7, respectively) (Table 2; Fig. 4). The gene discussed is MDM2; the disease is neoplasm.